Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Stellate Ganglion Block in Dysphagic Patients With Bulbar Palsy After Ischemic Stroke

NCT06335316 is registered in ClinicalTrials.gov with Copka Sonpashan as lead sponsor.

NCT NCT06335316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06335316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Stellate Ganglion Block in Dysphagic Patients With Bulbar Palsy After Ischemic Stroke
Lead sponsor
Copka Sonpashan
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2022
Completion date
May 28, 2023
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dysphagia